4
Changes in Ownership
PULSE BIOSCIENCES, INC. Filed Acc 0001437749-25-029104
Chief Technology Officer sold 75,000 shares at an average $14.96 ($1,121,750)
- Chief Technology Officer acquired 75,000 shares (option exercise)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
UECKER DARRIN · Chief Technology Officer
Table I: Non-derivative
6 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2025-09-11 | Exercise or conversion : show line 1 in the form 10b5-1 | +25,000 | $4.00 | $100,000 | 147,872 | D |
| 2025-09-11 | Sale : show line 2 in the form 10b5-1 | −25,000 | $14.78 | $369,500 | 122,872 | D |
| 2025-09-12 | Exercise or conversion : show line 3 in the form 10b5-1 | +25,000 | $4.00 | $100,000 | 147,872 | D |
| 2025-09-12 | Sale : show line 4 in the form 10b5-1 | −25,000 | $14.32 | $358,000 | 122,872 | D |
| 2025-09-15 | Exercise or conversion : show line 5 in the form 10b5-1 | +25,000 | $4.00 | $100,000 | 147,872 | D |
| 2025-09-15 | Sale : show line 6 in the form 10b5-1 | −25,000 | $15.77 | $394,250 | 122,872 | D |
| Open-market sales · 75,000 sh · avg $14.96 · $1,121,750 | ||||||
Table II: Derivative
3 lines| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2025-09-11 | Exercise or conversion : show line 7 in the form 10b5-1 Stock Option (right to buy) | −25,000 | 156,534 | D |
| 2025-09-12 | Exercise or conversion : show line 8 in the form 10b5-1 Stock Option (right to buy) | −25,000 | 131,534 | D |
| 2025-09-15 | Exercise or conversion : show line 9 in the form 10b5-1 Stock Option (right to buy) | −25,000 | 106,534 | D |
Loading xslF345X05/rdgdoc.xml…